Loading organizations...
Key people at Essential Medical LLC.
Based in Exton, Pennsylvania, Essential Medical LLC is a medical device manufacturer that developed the Manta vascular closure device for sealing large bore arteriotomies following interventional cardiac catheterization procedures. The CE-marked technology utilizes a specialized resorbable collagen mechanism to achieve rapid hemostasis in femoral puncture sites ranging from 10F to 18F in size. The product primarily targets the interventional cardiology and structural heart markets, specifically assisting physicians performing complex endovascular interventions such as transcatheter aortic valve replacement and endovascular aneurysm repair. Although the device was not yet approved for commercial sale within the United States at the time, clinical studies demonstrated non-inferior complication rates compared to traditional surgical suture methods. Consequently, the privately held enterprise was fully acquired by Teleflex Incorporated on October 4, 2018. Essential Medical LLC was founded in 2010 by Greg Walters and Dr. Gary Roubin.
Key people at Essential Medical LLC.
Essential Medical LLC (also referred to as Essential Medical, Inc.) was a privately held medical device company that developed innovative vascular closure devices for femoral punctures following diagnostic and interventional cardiac catheterization procedures.[1][3][4] These devices aimed to reduce hemostasis time, minimize complications like bleeding or hematoma, and speed patient recovery, serving hospitals, cardiovascular clinics, and interventional radiology centers.[1] The company raised $22.18M in funding before being acquired by Teleflex Medical on October 4, 2018, marking successful growth momentum in the vascular closure market.[4]
Founded in 2010 by Greg Walters, a senior product development executive with 20 years in cardiovascular innovations, and Dr. Gary Roubin, MD, PhD, a pioneer in coronary and carotid stenting, Essential Medical emerged to address unmet needs in vascular closure post-catheterization.[1][3] Headquartered in Exton, Pennsylvania, with 1-10 employees, the company focused on evolving small bore and transforming large bore closure markets for safer, faster procedures.[1][4] Early traction built through FDA-approved products and investments from Teleflex, DSM Venturing, Amzak Capital Management, and Ben Franklin Technology Partners, culminating in its 2018 acquisition.[1][4]
Essential Medical rode the trend toward minimally invasive cardiac procedures, where femoral access complications like vascular injury affect up to 5-10% of cases, driving demand for reliable closure tech.[1] Timing aligned with rising PCI volumes and emphasis on outpatient cath labs, amplified by post-2010 medtech investments in patient safety.[4] Market forces favoring it included aging populations increasing cardiovascular disease and regulatory pushes for complication-reducing devices.[1] Post-acquisition by Teleflex, its tech bolstered the ecosystem by integrating into larger portfolios, influencing standards in vascular access management.[4]
Now part of Teleflex since 2018, Essential Medical's devices continue advancing vascular closure, with potential expansion into next-gen materials or AI-guided deployment amid rising endovascular procedures.[4] Trends like value-based care and ambulatory surgery centers will shape its trajectory, emphasizing complication-free outcomes. Its influence may evolve through Teleflex's global scale, setting benchmarks for safer cath labs and inspiring similar medtech innovations—echoing its founding mission to transform post-procedure recovery.[1][4]
